Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
38.49%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth38.49%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
Dermata Therapeutics Inc fundamental performance
Across Dermata Therapeutics Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 7M to -$ 7M. Revenue increased in 0% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.38 | — |
1 Year2025-08-12 | $ 6.11 | -77.41% |
All Time2021-08-13 | $ 12.46K | -99.99% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2021-08-13 |
|---|---|---|---|
| Price | $ 1.38 | $ 6.11 | $ 12.46K |
| Return | — | -77.41% | -99.99% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 7M | $ 7.52B |
| 2024 | $ 0.00 | -$ 12M | $ 3M |
| 2023 | $ 0.00 | -$ 7M | $ 7M |
| 2022 | $ 0.00 | -$ 9M | $ 6M |
| IPO2021 | $ 0.00 | -$ 7M | $ 10M |
Explore beyond DRMA
You're looking at Dermata Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
